Journal of Oncology Practice Podcast
Summary: Journal of Oncology Practice (JOP) provides oncologists and other oncology professionals with information and tools to enhance practice efficiency and promote a high standard for quality of patient care. The goal of JOP is to be the authoritative resource on clinical and administrative management for practicing oncologists. The Journal includes original research, feature articles, and section columns on various issues pertinent to daily practice operations, all of which are subject to peer review.
- Visit Website
- RSS
- Artist: Journal of Oncology Practice
- Copyright: Copyright by the American Society of Clinical Oncology
Podcasts:
by Robert S. Miller, MD. Dr. Lee Newcomer of United Healthcare discussed the results of a pilot study of a novel episode payment model coupled with actionable use and quality data as an incentive to improve quality and reduce costs of care.
by Robert S. Miller, MD. Dr. Anees Chagpar discusses findings from the CDC’s 2010 National Health Interview Survey demonstrating a strong correlation between the financial burden of cancer and self-reported quality of life in cancer survivors.
by Robert S. Miller, MD. Dr. Russ Hoverman of Texas Oncology discusses ASCO's and ASTRO's participation in the Choosing Wisely campaign and the important concept of value in oncology.
by Robert S. Miller, MD. Stephanie Roberson Barnard discusses her first-person narrative describing the barriers she faced in receiving high-quality, patient-centered care when she was recently treated for breast cancer and some suggestions for improvement.
by Robert S. Miller, MD. Dr. Kerin Adelson discusses the implementation of Epic’s Beacon chemotherapy ordering platform at the Tisch Cancer Institute of Mt. Sinai, New York, and introduces a new quality metric called the rate of evidence-based adherence (REBA), used to measure clinic and provider performance and increase evidence-based practice.
by Robert S. Miller, MD. Tom Barr and Elaine Towle of Oncology Metrics discuss the state of oncology practice based on data from the annual National Practice Benchmark report, noting the marked resilience and adaptability of the oncology delivery system and the surprising degree of stability of the business structures for many of today’s physician-owned practices.
by Robert S. Miller, MD. Dr. Reshma Jagsi and collaborators conducted interviews with medical oncologists to ascertain their attitudes toward and prior experiences with the systematic collection of patient-reported outcomes (PROs) in community oncology and to identify barriers to wider implementation.
by Robert S. Miller, MD. Dr. Douglas Blayney reviews some of the research and presentations from the first ASCO Quality Care Symposium held in San Diego (Nov. 30 - Dec. 1, 2013), and covered in the special May 2013 issue of the JOP.
By Robert S. Miller, MD. Michael Neuss and Martha Polovich discuss the recent updates to the ASCO/ONS chemotherapy administration standards, focusing on the safe administration and management of oral chemotherapy.
by Robert S. Miller, MD. Medical oncologists Mike Thompson and Don Dizon join Claire Johnston, social media manager at ASCO, in a discussion of best practices in using social media for patient education, promotion of clinical trials, and professional networking for oncologists.
by Robert S. Miller, MD. Dr. Anupama Kurup, Chair-Elect of the ASCO Clinical Practice Committee, discusses some early findings from ASCO’s recent census and survey of oncology practices in the U.S.
by Robert S. Miller, MD. Dr. Joseph Herman and Dr. Amol Narang of Johns Hopkins discuss how direct-to-consumer advertising is being used by some providers and medical centers to aggressively promote stereotactic radiation therapy.
by Robert S. Miller, MD. Elaine Towle and Tom Barr from Oncology Metrics discuss their annual National Practice Benchmark Report, and looking at 2011 data, revise last year's predictions and project trends for the next 3 years.
By Robert S. Miller, MD. Linda Parreco, RN, MS of the NCI describes some evidence-based communication strategies that can be used to improve clinical trial discussions with patients.
by Robert S. Miller, MD. Dr. Jeffrey Peppercorn of Duke discusses the ethical issues raised when a patient declines potentially curative therapy for breast cancer.
